Wave Life Sciences (WVE) Change in Account Payables (2014 - 2026)
Wave Life Sciences (WVE) posted Change in Account Payables of $3.3 million for Q1 2026, up 184.52% on a QoQ basis from $1.2 million in Q4 2025, and up 260.28% year-over-year from $912894.4 in Q1 2025.
Wave Life Sciences (WVE) Change in Account Payables (2014 - 2026) Analysis & Trends
Wave Life Sciences' Change in Account Payables history runs 13 years deep, the most recent figure standing at $3.3 million for Q1 2026.
- Quarterly Change in Account Payables rose 260.28% year-over-year to $3.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.8 million (up 96.14% YoY) and the FY2025 annual result came in at -$561000.0, down 116.4% from the prior year.
- Change in Account Payables was $3.3 million for Q1 2026 at Wave Life Sciences, up from $1.2 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $6.1 million in Q2 2024 and bottomed at -$5.1 million in Q3 2024.
- A 5-year average of $690352.9 and a median of $503000.0 in 2023 frame the typical range for Change in Account Payables.
- Peak annual rise in Change in Account Payables reached 2701.38% in 2024, while the deepest fall reached 1109.54% in 2024.
- Wave Life Sciences' Change in Account Payables stood at $1.0 million in 2022, then plunged by 81.01% to $192000.0 in 2023, then soared by 1702.08% to $3.5 million in 2024, then slumped by 66.59% to $1.2 million in 2025, then jumped by 184.52% to $3.3 million in 2026.
- Business Quant data shows WVE's Change in Account Payables at $3.3 million in Q1 2026, $1.2 million in Q4 2025, and $59000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Wave Life Sciences | 1.16 Bn | 612.38 Mn | - | 3.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.29 Mn |
| Mar 31, 2026 | 3.29 Mn |
| Dec 31, 2025 | 1.16 Mn |
| Dec 31, 2025 | 1.16 Mn |
| Sep 30, 2025 | 59,000.00 |
| Sep 30, 2025 | 59,000.00 |
| Jun 30, 2025 | 276,000.00 |
| Jun 30, 2025 | 276,000.00 |
| Mar 31, 2025 | -2.05 Mn |
| Mar 31, 2025 | -2.05 Mn |
| Dec 31, 2024 | 3.46 Mn |
| Dec 31, 2024 | 3.46 Mn |
| Sep 30, 2024 | -5.08 Mn |
| Sep 30, 2024 | -5.08 Mn |
| Jun 30, 2024 | 6.11 Mn |
| Jun 30, 2024 | 6.11 Mn |
| Mar 31, 2024 | -1.07 Mn |
| Mar 31, 2024 | -1.07 Mn |
| Dec 31, 2023 | 192,000.00 |
| Dec 31, 2023 | 192,000.00 |